Advertisement

Topics

Medicalbit Foundation Co., Ltd. To Make ASCA Tokens Public

20:00 EDT 14 Mar 2019 | Businesswire

Medicalbit Foundation Co., Ltd.

The Medicalbit Foundation, which is currently undergoing an initial virtual currency coin offering (ICO) in Estonia, has decided to make its ASCA tokens publicly available as the first step in the Asclepius Network project.

The goal of Asclepius Network is to make leading-edge medical treatment available to all peoples of the world, and Japan has been chosen for the first location in Asia to expand business.
The project’s mission is to accumulate the world’s cutting-edge medical treatment knowledge and medical records within a blockchain system. This would form a mechanism that would enable anyone in the world to receive the benefits of leading-edge medical treatments anywhere in the world. To further that end, the project is forming a network of leading-edge medical researchers from Japan, as well as from Europe and the United States.
In practical terms, the project is engaged in the development of next-generation electronic medical records as well as the development of smart device apps to gather existing medical records. At this point, the project has already been approved for six patents in Japan.
Plans call for the establishment of blood and cancer screening facilities in 2019, using state of the art technologies from Japan, in conjunction with major diagnostic centers that are already involved in health screenings for millions of persons annually within China, as well as with the major hospital groups that manage dozens of hospitals within China.
In addition, proof-of-concept testing has already begun for a service to deliver Japanese pharmaceuticals to patients suffering from chronic illnesses.
This effort within China is initially estimated, based on preliminary calculations made with project partners, to reach an annual scope ranging from several tens of billions of yen to several hundreds of billions of yen.

Furthermore, a monetary fund has been established to allow participation within the sustainable development goals project set forth by the United Nations as a means to realize the project’s ideal of offering the benefits of leading-edge medical treatment to the peoples of the world. Plans call for the fund to be used predominantly for fields that include the free provision of treatment to areas of the world currently beyond the reach of such treatment.

Participation in the Asclepius Network project for these efforts will require ASCA tokens, and the project seeks investors and business partners interested in bringing leading-edge medical treatment to all the peoples of the world.

Description of Offering: Thursday, March 21st, 10:00 AM JST
Offering Trader: TopForce
URL: www.top-force.com/

Moving forward, plans call for global development based on joint work with partners in the countries of Asia, including Singapore, Malaysia, and India, following a model similar to that used for China. There will also be incremental increases to the number of offering traders from April of 2019 onward.

ICO Implementation Company: MEDICALBIT FOUNDATION OÜ
Harju maakond, Tallinn, Kesklinna linnaosa, Narva mnt 5, 10117

MBC URL: https://www.medicalbit.ee/
ASCA URL: https://www.asclepius.network/
Project Management Company: Japan Medical Solutions Co., Ltd.
9F Nihonbashi Ningyocho Ishii Building, 3-1-17 Ningyo-cho Nihonbashi, Chiyoda Ward, Tokyo
JPM URL: http://www.jpmedsn.com/

Inquiries:
Medicalbit Foundation
Hiroo Uchiyama
info@medicalbit.io

NEXT ARTICLE

More From BioPortfolio on "Medicalbit Foundation Co., Ltd. To Make ASCA Tokens Public"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...